Hepatitis B reactivation is rare after switching from tenofovir, two European studies show
Second Berlin patient has unusual immune response that seems to have removed his HIV
Resistance following failure of injectable cabotegravir/rilpivirine may limit future treatment options
More Europeans are dying from HIV now than 15 years ago
People with HIV report little difference in quality of life compared with matched controls, but more depression
Turning HIV’s power against itself may help target hidden virus – another step towards a cure
Low-level but detectable HIV raises the risk of treatment failure, but not long-term harm
Despite U=U, concerns about sharing HIV status persist among older people
Trans and gender diverse people face multiple barriers accessing UK sexual health services